The contribution of CYP2C gene subfamily involved in epoxygenase pathway of arachidonic acids metabolism to hypertension susceptibility in Russian population

References

• Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289:2560–2572.
   Google Scholar
• Joffres M, Falaschetti E, Gillespie C, et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open 2013;3(8):e003423.
   PubMed Web of Science ®Google Scholar
• Ehret GB, Munroe PB, Rice KM, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011;478:103–109.
   PubMed Web of Science ®Google Scholar
• Basson J, Simino J, Rao DC. Between candidate genes and whole genomes: time for alternative approaches in blood pressure genetics. Curr Hypertens Rep 2012;14:46–61.
   PubMed Web of Science ®Google Scholar
• Ehret GB, Caulfield MJ. Genes for blood pressure: an opportunity to understand hypertension. Eur Heart J 2013;34:951–961.
   PubMed Web of Science ®Google Scholar
• Padmanabhan S, Caulfield M, Dominiczak AF. Genetic and molecular aspects of hypertension. Circ Res 2015;116:937–959.
   PubMed Web of Science ®Google Scholar
• Singh M, Singh AK, Pandey P, et al. Molecular genetics of essential hypertension. Clin Exp Hypertens 2016;38:268–277.
   PubMed Web of Science ®Google Scholar
• Theken KN, Schuck RN, Edin ML, et al. Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease. Atherosclerosis 2012;222:530–536.
   PubMed Web of Science ®Google Scholar
• Bellien J, Joannides R. Epoxyeicosatrienoic acid pathway in human health and diseases. J Cardiovasc Pharmacol 2013;61:188–196.
   PubMed Web of Science ®Google Scholar
• Imig JD. Epoxyeicosatrienoic acids, hypertension, and kidney injury. Hypertension 2015;65:476–482.
   Google Scholar
• Capdevila J, Wang W. Role of cytochrome P450 exoxygenase in regulating renal membrane transport and hypertension. Curr Opin Nephrol Hypertens 2013;22:163–169.
   PubMed Web of Science ®Google Scholar
• Spector AA, Kim HY. Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism. Biochim Biophys Acta 2015;1851:356–365.
   PubMed Web of Science ®Google Scholar
• Theken KN, Lee CR. Genetic variation in the cytochrome P450 epoxygenase pathway and cardiovascular disease risk. Pharmacogenomics 2007;8:1369–1383.
   PubMed Web of Science ®Google Scholar
• Zordoky BN, El-Kadi AO. Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases Pharmacol Ther 2010;125:446–463.
   Google Scholar
• McGiff JC. Cytochrome P450 metabolism of arachidonic acid. Annu Rev Pharmacol Toxicol 1991;31:339–369.
   PubMed Web of Science ®Google Scholar
• Wu S, Moomaw CR, Tomer KB, et al. Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J Biol Chem 1996;271:3460–3468.
   PubMed Web of Science ®Google Scholar
• Lee CR, Imig JD, Edin ML, et al. Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice. FASEB J. 2010;24:3770–3781.
   PubMed Web of Science ®Google Scholar
• King LM, Gainer JV, David GL, et al. Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension. Pharmacogenet Genomics 2005;15:7–13.
   PubMedGoogle Scholar
• Dreisbach AW, Japa S, Sigel A, et al. The Prevalence of CYP2C8, 2C9, 2J2, and soluble epoxide hydrolase polymorphisms in African Americans with hypertension. Am J Hypertens 2005;18:1276–1281.
   PubMed Web of Science ®Google Scholar
• Wu SN, Zhang Y, Gardner CO, et al. Evidence for association of polymorphisms in CYP2J2 and susceptibility to essential hypertension. Ann Hum Genet 2007;71:519–525.
   PubMed Web of Science ®Google Scholar
• Ma Y, Ni W, Zhu W, et al. Association of genetic polymorphisms of CYP 2C19 with hypertension in a Chinese Han population. Blood Press 2011;20:166–170.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Amjad A, Fu Z, et al. Single nucleotide polymorphism of the CYP2J2 gene is associated with essential hypertension in Uygur population in China. Biochem Anal Biochem 4:159.
   Google Scholar
• Shin DJ, Kwon J, Park AR, et al. Association of CYP2C19*2 and *3 genetic variants with essential hypertension in Koreans. Yonsei Med J 2012;53:1113–1119.
   PubMed Web of Science ®Google Scholar
• Alghasham A, Ali A, Ismail H, et al. CYP2J2 −50 G/T and ADRB2 G46A gene polymorphisms in Saudi subjects with hypertension. Genet Test Mol Biomarkers 2012;16:1027–1031.
   PubMed Web of Science ®Google Scholar
• Ali AAA, Wassim NM, Dowaidar M, Yaseen AE. Association of eNOS (E298D) and CYP2J2 (− 50G/T) gene polymorphisms with hypertension among Egyptian cases. The Journal of Basic and Applied Zoology 2013;66:234–241.
   Google Scholar
• Polonikov AV, Ivanov VP, Solodilova MA, et al. A common polymorphism G-50T in cytochrome P450 2J2 gene is associated with increased risk of essential hypertension in a Russian population. Dis Markers 2008;24:119–126.
   PubMed Web of Science ®Google Scholar
• Tzveova R, Naydenova G, Yaneva T, et al. Gender-specific effect of CYP2C8*3 on the risk of essential hypertension in Bulgarian patients. Biochem Genet 2015;53:319–333.
   PubMed Web of Science ®Google Scholar
• Bushueva O, Solodilova M, Churnosov M, et al. The flavin-containing monooxygenase 3 gene and essential hypertension: the joint effect of polymorphism E158K and cigarette smoking on disease susceptibility. Int J Hypertens 2014;2014:712169.
   PubMedGoogle Scholar
• Polonikov AV, Ushachev DV, Ivanov VP, et al. Altered erythrocyte membrane protein composition mirrors pleiotropic effects of hypertension susceptibility genes and disease pathogenesis. J Hypertens. 2015;33:2265–2277.
   PubMed Web of Science ®Google Scholar
• Xu Z, Taylor JA. SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res 2009;37 (Web Server issue):W600–W605.
   PubMed Web of Science ®Google Scholar
• González JR, Armengol L, Solé X, et al. SNPassoc: an R package to perform whole genome association studies. Bioinformatics 2007;23:644–645.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Antona C, Niemi M, Backman JT, et al. Characterization of novel CYP2C8 haplotypes and their contribution to paclitaxel and repaglinide metabolism. Pharmacogenomics J 2008;8:268–277.
   PubMed Web of Science ®Google Scholar
• Kirchheiner J, Meineke I, Fuhr U, et al. Impact of genetic polymorphisms in CYP2C8 and rosiglitazone intake on the urinary excretion of dihydroxyeicosatrienoic acids. Pharmacogenomics 2008;9:277–288.
   PubMed Web of Science ®Google Scholar